Counterfeit medicine and drugs are a major problem in Pakistan that have caused not only patients but healthy people simply in search of supplements become prey to diseases that can be easily avoided otherwise.
Fighting this longstanding battle of fake drugs in the country is a local startup called ProCheck, founded in 2014, ProCheck provides unique codes printed on medicines that consumers can use to confirm whether the drug they have bought is genuine or not. ProCheck works with leading pharmaceutical firms like Getz Pharma, Ferozsons Labs, Nabi Qasim and Shabbir Tiles.
They have recently secured $250,000 in seed funding round led by Sarmayacar joined by Pakathon/Elastica. Through this funding ProCheck is to expand its sales and engineering team to capitalize on the surge of interest from the pharmaceutical industry in particular and will enable it to establish sales and service presence in manufacturing hubs outside Karachi, where it is headquartered.
Rabeel Warraich, Founder Sarmayacar has joined the Board of Directors for the startup as part of the funding. Speaking on the occasion he said,
“By offering the full stack of track and trace capabilities, SMS and app based verification services, coupled with a strong focus on analytics and patient engagement, ProCheck has established itself as the provider of choice for the pharmaceutical industry.”
Saim Siddiqui speaking on the occasion said,
“We’re focused on our mission of enabling patient access to authentic and affordable drugs, by protecting the supply chain and empowering the purchaser.”